Stay updated on Adjuvant Therapy in Stage III BRAF+ Melanoma Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Therapy in Stage III BRAF+ Melanoma Clinical Trial page.

Latest updates to the Adjuvant Therapy in Stage III BRAF+ Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe changes show an added revision note (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure item from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe Record History now shows a new revision entry v3.3.2, replacing the previous v3.3.1.SummaryDifference0.1%

- Check33 days agoChange DetectedNew revision v3.3.1 added and revision v3.2.0 removed from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved a general government funding/operating status notice from the page; this change does not affect the study data or availability of information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check54 days agoChange DetectedThe new screenshot shows updates to the version history list and minor UI/layout tweaks. There is no visible change to core study information such as the protocol, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedMajor change: update to v3.2.0 and a prominent notice about funding-related accessibility and operating status; indicates the page is now at a newer version and provides guidance on where to check status.SummaryDifference10%

Stay in the know with updates to Adjuvant Therapy in Stage III BRAF+ Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Therapy in Stage III BRAF+ Melanoma Clinical Trial page.